Compositions comprising cross-species-specific antibodies and uses thereof

Details for Australian Patent Application No. 2006301492 (hide)

Owner Micromet AG

Inventors Kufer, Peter; Schlereth, Bernd; Kischel, Roman; Raum, Tobias; Rau, Doris; Cierpka, Ronny

Agent Pizzeys

Pub. Number AU-B-2006301492

PCT Pub. Number WO2007/042261

Priority 60/724,781 11.10.05 US

Filing date 10 October 2006

Wipo publication date 19 April 2007

Acceptance publication date 9 June 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/042261 Priority application(s): WO2007/042261

9 June 2011 Application Accepted

  Published as AU-B-2006301492

6 October 2011 Standard Patent Sealed

20 September 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Amgen Research (Munich) GmbH . Address for service in Australia - Pizzeys Patent and Trade Mark Attorneys Level 20 324 Queen Street Brisbane QLD 4000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006301493-Ophthalmic emulsions containing prostaglandins

2006301487-Non-invasive in vitro method to detect transitional cell carcinoma of the bladder